© 2021 MJH Life Sciences and HCPLive - Clinical news for connected physicians. All rights reserved.
© 2021 MJH Life Sciences™ and HCPLive - Clinical news for connected physicians. All rights reserved.
On the HCPLive psoriatic arthritis page, resources on the topics of medical news and expert insight into PsA can be found. Content includes articles, interviews, videos, podcasts, and breaking news on arthritis, and more.
September 21, 2021
Results show how patients with psoriatic arthritis prioritize their decisions when choosing medication.
August 24, 2021
Investigators found that patients who were not treated with biologic medications were at a significantly increased risk of developing psoriatic arthritis.
August 11, 2021
Dr. Blauvelt speaks on the results of the phase 3b Heads Up study, and the future of upadacitinib and dupilumab in atopic dermatitis management.
July 28, 2021
Researchers record more depressive symptoms in patients with psoriatic arthritis, which they believe incentivizes doctors to utilize screening methods that focus on the mental health of a patient.
July 21, 2021
Researchers from France challenge previous reports of the IL-17 inhibitor treatment resulting in an increased risk of inflammatory bowel disease in patients with immune disorders like psoriasis.
July 16, 2021
Patients with psoriatic arthritis often feel limited in their knowledge on medications and treatments, which investigators said leads to a lack of treatment and increased risk of disability.
April 25, 2021
A comparison of pooled phase 3 data showed patients treated with the IL-17A inhibitor fared better than those on ustekinumab, without influence from their PsA status.
April 24, 2021
A post-hoc analysis shows that the human monoclonal antibody was linked to sustained improvements according to different disease measurements through week 52.
April 22, 2021
A majority of studies reported a worsening of disease activity post-delivery.
April 16, 2021